Benign prostatic hyperplasia (BPH), or an enlarged prostate, affects millions of men and becomes increasingly common with age, yet treatment options have traditionally centered on medication, monitoring or surgery. During National Prostate Health Month this September, new research into pulsed electromagnetic field (PEMF), or frequency therapy, is putting a spotlight on a noninvasive technology as another approach to supporting men with BPH. The findings come as AuraWell continues to expand the conversation around drug-free, noninvasive treatment options.
AuraWell is exploring the use of frequency therapy (PEMF) in this area. Its patented, FDA-cleared PEMF devices were recently evaluated in a collaborative pilot study involving four patients with BPH. Participants received twice-daily frequency therapy treatments and underwent ultrasound scans to monitor prostate volume. After one month, researchers observed prostate volume reductions of up to 30% among participants, with no adverse effects reported during the study period.
“These findings give us an exciting reason to continue studying what frequency therapy may be able to offer men with BPH,” said Alane Paulley, CEO of AuraWell. “What if helping a man manage his prostate health meant one less trip to the bathroom at night? What if that meant one more hour of uninterrupted, restful sleep, or simply feeling more confident and comfortable throughout his day? That’s why research like this is so important. We’re exploring whether a noninvasive approach like using the Aura Wave could play a role in helping men feel better, sleep better, and live better. We’re excited to continue learning what that could mean for the future of men’s health,” Paulley added.
Research published in 2025 in the journal BMC Urology reports that BPH affects an estimated 50% to 75% of men over age 50, with prevalence increasing to approximately 80% by age 70. The condition can significantly affect quality of life and has been associated with health concerns including depression and an increased risk of falls. Researchers project that the global burden of BPH will continue to rise through 2035.
According to the National Institutes of Health, BPH occurs when the prostate becomes enlarged but is not cancerous. The condition can cause urinary symptoms and, in some cases, complications including urinary tract infections, bladder stones, bladder damage and kidney problems. Depending on the severity of symptoms, treatment may range from watchful waiting and lifestyle changes to medication or surgery.
PEMF (Pulsed Electromagnetic Field) uses pulsed electromagnetic signals to support cellular activity and natural recovery processes. The technology has been studied across a range of therapeutic applications, and researchers are now examining its potential role in additional areas, including BPH. The pilot findings provide proof of the Aura Wave frequency therapy device as a potential noninvasive approach for men with BPH.
Those experiencing symptoms of BPH should speak with their doctor to be evaluated for the condition. According to the NIH, symptoms may include:
- Trouble starting a urine stream or emptying the bladder
- A weak or interrupted urine stream or dribbling at the end of urination
- Waking up often to urinate during the night
- Urinary urgency or frequency
- Pain during urination
“We are encouraged by the findings of this study and what the results say about PEMF technology, or frequency therapy, for men with BPH,”Paulley added. “For the millions of men affected by an enlarged prostate, there is a real need to continue exploring noninvasive approaches that may complement existing treatment options. We are excited to continue exploring frequency therapy as a noninvasive approach to BPH research and the broader conversation around the future of men’s health.”
AuraWell continues to support research exploring new applications for PEMF technology while expanding access to its FDA-cleared Aura Wave device for at-home use.
For more information about AuraWell and its frequency therapy technology, visit AuraWell.com.
